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Orthopaedic surgery is a long established surgical specialty. Practitioners complete training which focuses on those
musculo-skeletal conditions for which surgery is the preferred treatment option. Diagnosis and assessment are
performed to exclude those for whom surgical intervention is not indicated. Finestone and others argue in their recent
IJHPR paper that we need a subspecialty to cater for these patients – medical orthopaedics. They explain that almost
all of the very many patients who seek help for musculo-skeletal conditions do not need surgery, and that orthopaedic
surgeons are ill equipped to deal with their complaints and have little to offer. Their paper sets out the case for a new
discipline of medical orthopaedics to complement the discipline of orthopaedic surgery.
This commentary examines the case for a new approach to musculo skelketal conditions. It discusses the steps which
might be needed to decide whether any new discipline should be established, and goes on to set the terms for a
debate on the merits of a multidisciplinary approach compared to a purely medical one. Leadership in clinical
disciplines has historically rested with medically qualified health professionals. Nowadays this has given way to an
understanding that health problems, especially long term conditions, commonly benefit from different expertises
coming together. For musculoskeletal conditions, might this be an example where the best outcome would be to look
beyond a medically led model?
This is a commentary on http://www.ijhpr.org/content/2/1/42/.Commentary
Why is this issue important?
Worldwide the burden of illness from musculo skeletal
conditions (MSC) is very large. Spending on investigations
and treatments is concomitantly sizeable. Many standard
aides and devices are expensive and lack an evidence base
for their efficacy. In an article in this journal written by
Finestone and colleagues they call for a better approach to
the assessment and treatment of the high proportion of
MSC sufferers where patients would not benefit from
surgical treatment [1]. They propose establishing a new
medical specialty – medical orthopaedics - that would
better tackle the needs of this group of patients.
Before examining the case to be made for a new
approach to non-surgical treatment of MSC, it is worth
estimating the scale of the problem. Consider the level
of expenditure by three nations (all sums are in US$),
using expenditure on cardiovascular disease as a reference
point. In 2008, Australia estimated that it spent about
$ 5.7 Billion (US $) on musculoskeletal disorders, and
approaching $ 8 Billion (US$) on cardiovascular diseaseCorrespondence: drschiller@email.com
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stated.[2]. In 2012, the UK NHS spent over $8 Billion (US$) on
musculo skeletal conditions, and $ 11 Billion (US$) on
circulatory disorders [3]. In the USA estimates showed
that patients with musculoskeletal conditions incurred
total annual medical care costs of approximately $240
billion, of which $77 billion was directly related to the
musculoskeletal conditions and the remainder to indirect
costs [4]. According to a 2006 review, total costs associated
with low back pain in the United States exceeded $100
billion that year, two thirds of which were a result of lost
wages and reduced productivity [5]. Coronary heart disease
costs the USA approximately $110 billion each year [6].
These estimates of spend demonstrate that the resources
committed to MSC are comparable with the funds devoted
to circulatory illness and are, using typically English
understatement, substantial.
The question of why there is no delineated medical spe-
cialty focusing on orthopaedic medicine isn’t original –
indeed I recall debating it when a medical student myself.
The response to the question during my student days was
that the area was covered by physiotherapists, to whom
physicians and surgeons alike could refer. The paper by
Finestone and colleagues argues that the MSC complaints
patients bring are commonplace and at present poorlyhis is an Open Access article distributed under the terms of the Creative
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http://www.ijhpr.org/content/2/1/43handled by clinical professionals. They propose training
medically qualified specialists to properly diagnose and set
out paths of treatment, and to gather a body of evidence
for the most effective actions for any given set of symptoms
and signs.
What do we know?
We know that MSC needing non-surgical interventions are
common. We know that there is no established, dedicated
medical specialty to which patients can turn. The authors
believe that the void presented by orthopaedics being
an essentially surgical-only specialty impedes proper diag-
nosis and appropriate treatment for the great majority of
people with MSC.
Patients seek help from a range of people they believe
have useful expertise, usually including at least some of
family doctors, rheumatologists, neurologists, rehabili-
tation specialists, gait specialists, physiotherapists, and
orthopaedic surgeons. They take a seemingly random
route on their journey to find symptom relief, shuttling
between one clinical specialty and another, sometimes
seeing several members of one clinical discipline before
discarding it in favour of another. The available sources of
help are not organised so as to guide people in deciding
which might be of greatest benefit. How do they know
which conditions deserve a visit to a rheumatologists, but
only after the family doctor has ruled out conditions not
dealt with by that specialty? People often spend a good
deal of either their own money or that of their insurers to
little effect. They seek relief from pain and improvement
of function but rarely achieve these goals easily. Dissat-
isfied, they try various clinicians, sometimes including
people trained in less well accredited disciplines such as
hypnosis, and sometimes people many might label as
medical charlatans.
All this activity is only enjoyed by those who have
insurance or the means to pay for their appointments
and treatments. There is a real ethical case to be made for
exploring this area of unmet need based on the strong
likelihood that people from the poorest backgrounds, who
commonly have worse health than those with greater
wealth, do not even have the opportunity to remedy their
suffering at present.
The authors highlight the extensive use of inappropriate
investigations carried out partly because insurers will
pay for them, and partly under pressure from patients
themselves. Patients commonly believe that imaging or
blood tests will lead to a correct diagnosis and will, at the
very least, allow the clinician to rule out sinister conditions
like cancer – a very real fear for many people and a key
reason offered when they are asked why they seek a
specialist opinion.
Imaging is only helpful when used against strict criteria,
but the fact that it might be covered by insurers means itis used far more widely than appropriate. Protocols
containing evidenced criteria have been developed in
many places, including examples from the UK [7,8].
Adhering to them cuts the numbers of imaging requests
made and fulfilled, saving patients anxiety and the health
system a great deal of money, without any loss of quality
or difference to outcomes. All imaging techniques have
some risk. Concomitant benefit must be shown where
imaging is to be used. Imaging is no substitute for a
proper physical examination, which should be far more
widely taught and practiced.What do we now need to know?
How will we judge if medical orthopaedics is a new discip-
line worthy of establishing in its own right? Some pertinent
issues were helpfully set out in a paper of 1965 where
the question of whether nuclear medicine is, or could be, a
speciality in its own right, was articulated [9]. Other spe-
cialties have drifted into being chiefly because some inter-
ested practitioners have announced that the discipline is to
exist and is, de facto, to be recognised, for example medical
geology [10]. For medical orthopaedics, however, I believe
that a more thoughtful, rigorous process will yield a better
outcome, and an outcome more readily understood and
adopted both in Israel and beyond.
What criteria might we need to make such a decision?
Firstly, it is essential to assess the burden of illness which
does not readily fit into any other discipline. Secondly, it is
necessary to gather information on the evidence base for
diagnosis and treatments and identify gaps where evidence
is lacking. Thirdly, there must be benefit to a sizeable group
of patients of adopting the model of a discipline focused on
their conditions. Ideally the benefits would be both health
and cost related. Fourthly, the case must be made for
setting up a medical discipline rather than a discipline
led by any other group of health professionals. As this
commentary, and the paper by Finestone, are read and
discussed, further criteria might be agreed.
Before deciding if a medical orthopaedics specialty is
warranted, it will be essential to bring accurate facts and
figures together. An appropriate group of clinicians should
review the categories of presenting symptoms and signs
which lead patients to seek help. The group should begin
by agreeing, in as clearly defined detail as possible, a tried
and tested rubric against which a cohort of cases can be
systematically analysed. Ideally the group would not be
limited to doctors with an interest in this area; rather,
it would include physiotherapists, psychologists, occupa-
tional therapists, nurses and others whose work would
allow them to contribute to the evidence gathering and
analysis. I believe there is a case for including some
patients, and certainly would support a debate on their
best place within this work.
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evidence of the size of the challenge, and delineating it and
its limits, so that any future specialty would be informed by
the best and most current agreed intelligence. The rubric
would best be developed and agreed internationally so that
any medical orthopaedic specialty will grow harmoniously
across the globe and readily compare data.
Other specialties have taken a great deal of time to reach
this point, but there are good examples of the powerful
importance of a careful process where it has happened.
For example, the regular 5-year international review of
evidence in emergency life support skills [11] published by
the American Heart Association has undoubtedly allowed
lives to be saved world-wide. The sharing of practice and
experience has been invaluable in setting standards
globally and on the continuous improvements of those
standards.
Beyond being helpful to garner accurate, current data
on the size and scale of the problem, it will be important
to determine which conditions are generally successfully
treated right now and which are not; and which treatments
or advice provide relief from symptoms most cheaply,
speedily and acceptably by patients, and which carry fewest
adverse effects.
We know, for example, that there is a free market in
orthotics, where the alchemy of the bronze plate of the
surgeon’s consulting room can lend weight to the purchase
of any suggested device, however scant the evidence for its
effectiveness. The data gathering exercise discussed above
will helpfully be complemented by a prospective study
of the actual spend now on (say) orthotics. The value of
the spend would help identify where funds might be
drawn should there be agreement to establish a medical
orthopaedic specialty. In a best case scenario, the resources
for this specialty might be drawn from funds saved from
ceasing non-evidence based investigations and interven-
tions, be they imaging, any other tests, drugs, devices or
other means intended to alleviate symptoms and improve
function.
What do we need to do once we have firm evidence?
Data alone will not address the issues. There is an import-
ant debate to be held on whether medical orthopaedics
should be an independent medical specialty, or a physio-
therapy domain, or one for primary care physicians with
an interest in medical orthopaedics (as some general
practitioners in the UK can be), or belongs with some
other specialist group. It may be that a multi-disciplinary
approach would be most successful. There is a need to
include, for instance, the place of movement and exercise
in remedying MSC. This might be a key element of treat-
ments, and one where non-doctors such as physiothera-
pists have the greatest knowledge and skills. It would be
very exciting to see a multi-disciplinary specialty wherethe leading experts were drawn from among doctors and
others as equals. This would send strong signals about the
sharing of key expertise between clinicians.
Debate should focus on fashioning a workable way
forward which is evidence based, feasible, as inexpensive
as possible, and using resources already within the systems
we have as far as is possible. Again, an important debate
is needed to articulate criteria against which progress to
an improved approach to non-surgical MSC could be
measured. The voices of patients should be present
from the beginning and will help shape the priorities of
any work in this arena. Patients have had real impact in
treatments for many long term conditions such as type
2 diabetes, and pain management. Solutions should be
acceptable to professional and patient alike.
Dr Finestone raises an important subject. I hope the
ensuing debate starts quickly, is lively, and leads to evi-
denced actions to meet the challenge of better diagnosing
and treating this large group of patients.
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